Part of a series on |
Indigenous rights |
---|
![]() |
Rights |
Governmental organizations |
United Nations initiatives |
International Treaties |
NGOs and political groups |
Issues |
Countries |
Category |
Biopiracy (also known as scientific colonialism) is the unauthorized appropriation of knowledge and genetic resources of farming and indigenous communities by individuals or institutions seeking exclusive monopoly control through patents or intellectual property.[1] While bioprospecting is the act of exploring natural resources for undiscovered chemical compounds with medicinal or anti-microbial properties, commercial success from bioprospecting leads to the company's attempt at protecting their intellectual property rights on indigenous medicinal plants, seeds, genetic resources, and traditional medicines.[2]
Moreover, if biological resources and traditional knowledge are taken from indigenous or marginalized groups, the commercialization of their natural resource can harm communities. Despite the medicinal and innovative benefits of bioprospecting and biochemical research, the expropriation of indigenous land for their genetic resources without fair compensation inevitably leads to exploitation. Biopiracy can harm indigenous populations in multiple ways. Without proper compensation or reward for traditional knowledge of natural resources, the sudden increase in commercial value of the species producing the active compound can make it now unaffordable for the native people. In some cases, a patent filed by the western company could prohibit the use or sale of the resource by any individual or institution, including the indigenous group. With nearly one third of all small-molecule drugs approved by the U.S. Food and Drug Administration (FDA) between 1981 and 2014 being either natural products or compounds derived from natural products, bioprospecting or piracy is growing more significantly, especially in the pharmaceutical industry.[3] Furthermore, the United Nations Educational, Scientific and Cultural Organization (UNESCO) mentions, in the context of intangible cultural heritage (ICH), that the medicinal traditions and knowledge of the Kallawaya communities in Peru have been affected by the lack of legal protection from pharmaceutical companies. A number of research projects are currently being developed on this subject, such as the research carried out using digital methods on the biopiracy of traditional medicines,[4][5] which shows the current context of the problem by developing a description and analysis of the data, and by visualising and mapping the various organisations and actors in the social networks.
With the advancement of extraction techniques of genetic material in biochemistry and molecular biology, scientists are now able to identify a specific gene, which directs to enzymes capable of converting one molecule to another.[6] This scientific breakthrough brings up the question of whether the organism containing the gene that has been modified through a series of tests and experiments should be accredited to the country of origin.